Skip to content

SANGRIX INC.: 20-F filed 2025-10-31

What SANGRIX INC. reported in its annual report (foreign private issuer) filed 2025-10-31 (fiscal FY 2025): 31 published measures, 83 facts as tagged in accession 0001104659-25-105009.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2025-10-31
Fiscal period
fiscal FY 2025
Accession
0001104659-25-105009 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANGRIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-303,536,440USD
At 2024-06-306,684,745USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-30372,083USD
At 2024-06-305,775,162USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-303,900,132USD
At 2024-06-301,662,644USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-3055,639USD
At 2024-06-301,409,070USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-2,290,607USD365
2023-07-01 to 2024-06-30-7,929,234USD366
2022-07-01 to 2023-06-30-6,761,587USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-07-01 to 2023-06-30115,033USD365

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2024-07-01 to 2025-06-3039,495USD365
2023-07-01 to 2024-06-302,888,482USD366
2021-07-01 to 2022-06-306,261,091USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-608,712USD365
2023-07-01 to 2024-06-308,298,774USD366
2022-07-01 to 2023-06-302,490,527USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-07-01 to 2025-06-301,545,888USD365
2023-07-01 to 2024-06-301,023,256USD366
2022-07-01 to 2023-06-304,269,529USD365

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-07-01 to 2025-06-3023,104,846shares365
2023-07-01 to 2024-06-305,241,577shares366
2021-07-01 to 2022-06-303,279,049shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-07-01 to 2025-06-3023,104,846shares365
2023-07-01 to 2024-06-305,241,577shares366
2021-07-01 to 2022-06-303,279,049shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-0.28USD/shares365
2023-07-01 to 2024-06-30-3.34USD/shares366
2021-07-01 to 2022-06-30-8.61USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-0.28USD/shares365
2023-07-01 to 2024-06-30-3.34USD/shares366
2021-07-01 to 2022-06-30-8.61USD/shares365

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-07-01 to 2024-06-3073,230USD366
2022-07-01 to 2023-06-3067,271USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-2,991,693USD365
2023-07-01 to 2024-06-30-14,835,793USD366
2021-07-01 to 2022-06-30-28,304,640USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-303,536,440USD
At 2024-06-306,684,745USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-30372,083USD
At 2024-06-302,491,170USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-07-01 to 2025-06-303,031,188USD365
2023-07-01 to 2024-06-3013,890,591USD366
2021-07-01 to 2022-06-3023,739,111USD365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-07-01 to 2025-06-3039,495USD365
2023-07-01 to 2024-06-30-945,202USD366
2021-07-01 to 2022-06-30-4,565,529USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-06-307,758,348shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-3074,471,809USD
At 2024-06-3081,066,562USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-06-303,164,357USD
At 2024-06-30909,583USD
At 2023-06-3010,261,071USD
At 2022-06-3034,654,956USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-4,369,906USD365
2023-07-01 to 2024-06-30-18,284,958USD366
2022-07-01 to 2023-06-30-28,216,352USD365
2021-07-01 to 2022-06-30-28,216,352USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-4,369,906USD365
2023-07-01 to 2024-06-30-18,284,958USD366
2022-07-01 to 2023-06-30-28,216,352USD365
2021-07-01 to 2022-06-30-28,216,352USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-6,533,987USD365
2023-07-01 to 2024-06-30-17,531,647USD366
2021-07-01 to 2022-06-30-28,216,352USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2025-06-303,082,820USD365
2023-07-01 to 2024-06-303,816,307USD366
2021-07-01 to 2022-06-302,914,612USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-07-01 to 2025-06-300USD365
2023-07-01 to 2024-06-30900,938USD366
2022-07-01 to 2023-06-305,361,955USD365

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-07-01 to 2025-06-30455,194USD365
2023-07-01 to 2024-06-30497,768USD366
2021-07-01 to 2022-06-30227,376USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-07-01 to 2025-06-30-1,378,213USD365
2023-07-01 to 2024-06-30-3,449,165USD366
2021-07-01 to 2022-06-3088,288USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-07-01 to 2025-06-30608,712USD365
2023-07-01 to 2024-06-30270,170USD366
2022-07-01 to 2023-06-3089,589USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-07-01 to 2024-06-30-667,912USD366
2022-07-01 to 2023-06-30667,912USD365

Inspect the source

Entity
SANGRIX INC. / CIK 0001735556
Captured
2026-09-21T17:25:29.977Z
SEC response SHA-256
35347f73859e801269c4493170eef9dfdd81524d77cc5cae387663aaf840b97a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001735556.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))